45 results
6-K
EX-99.2
CNTG
Centogene NV
28 Nov 23
CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction
6:30am
research and development, clinical and laboratory services in accordance in all material respects with all Applicable Laws; and
any regulatory
6-K
EX-99.4
CNTG
Centogene NV
28 Nov 23
CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction
6:30am
in the Laboratory Services Agreement) to Company under the Laboratory Services Agreement;
conducting internal research and development at the NV Facility … material respects;
NV and its Affiliates have conducted all research and development of NV Technology in accordance with all Applicable Laws; and
all
6-K
EX-99.1
CNTG
Centogene NV
7 Sep 23
CENTOGENE Reports First Half 2023 Financial Results
5:00pm
an improvement in gross profit of 6.5%, with a 24.5% reduction in research and development (R&D) expenses partially being offset by higher selling … % (excluding Share Base Payments) and research and development expenses (“R&D”) by 24.5%. The positive impact has been somewhat offset by one-off
6-K
EX-99.2
CNTG
Centogene NV
7 Sep 23
CENTOGENE Reports First Half 2023 Financial Results
5:00pm
of comprehensive loss
(in EUR k)
For the six months ended June 30
Revenue
Cost of sales
Gross profit
Research and development expenses
General administrative …
Research and development expenses
For the six months ended June 30, 2022
in EUR k
Pharmaceutical
Diagnostics
Corporate
Total Revenues from contracts
6-K
EX-99.1
CNTG
Centogene NV
12 Jul 23
Current report (foreign)
7:30am
further research, clinical development, and ultimately, improved patient outcomes.”
To read the full study, visit: https://link.centogene.com/npc1
6-K
EX-99.2
mmba72re cx7paof
22 Dec 22
CENTOGENE Reports Second Quarter and First Half 2022 Financial Results
4:13pm
6-K
EX-99.1
gbnakln u7
22 Dec 22
CENTOGENE Reports Second Quarter and First Half 2022 Financial Results
4:13pm
6-K
EX-99.1
gabor3x uv
3 Nov 22
Current report (foreign)
6:05am
6-K
EX-99.3
shf f089rpylffes
15 Jul 22
CENTOGENE Reports First Quarter 2022 Financial Results
9:37am
6-K
EX-99.2
h1fxolhxfv41g m6rqgs
15 Jul 22
CENTOGENE Reports First Quarter 2022 Financial Results
9:37am
6-K
EX-99.1
ocbp26 54c6re
30 Mar 22
CENTOGENE Reports Fourth Quarter and Fiscal Year 2021 Financial Results
7:54am
6-K
EX-99.1
3exr37
20 Jan 22
Current report (foreign)
7:03am
6-K
EX-99.2
5dobbzumswz60u0
24 Nov 21
CENTOGENE Reports Third Quarter 2021 Financial Results
7:41am
6-K
EX-99.3
iw17g8 uep48j
24 Nov 21
CENTOGENE Reports Third Quarter 2021 Financial Results
7:41am
6-K
EX-99.2
k9by xswd
7 Sep 21
CENTOGENE Reports Second Quarter 2021 Financial Results
6:20am
6-K
EX-99.3
zpv12 yvsrr
7 Sep 21
CENTOGENE Reports Second Quarter 2021 Financial Results
6:20am
6-K
EX-99.3
qv7ah ajtss
16 Jun 21
CENTOGENE Reports First Quarter 2021 Financial Results in the Lead Up to
6:54am
6-K
EX-99.2
8z8i5g1o abw765
16 Jun 21
CENTOGENE Reports First Quarter 2021 Financial Results in the Lead Up to
6:54am